Infosys Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/35phnz5pmbuvl2urxa8niwbe.pdf

Key Takeaways


Demand Environment

Parekh: "The previous guidance was 1% to 3%, and now it is 2% to 3%. So, in a sense, we have much more confidence with the lower end being increased in what we see into the outlook for the year."

Deal Wins & Large Deals

Parekh: "With some of the AI tools, the time horizon becomes less and as a consequence, the ROI for the client on that program is much better."

Margins & Project Maximus

Margin walk (QoQ)Impact
Project Maximus (pricing, lean, automation, program optimization)+30 bps
Currency tailwinds+60 bps
Higher subcon costs and lower onsite utilization–70 bps (offset)
Net change → 21.0%+20 bps

AI & GenAI

Parekh: "We believe there is a huge amount of opportunity in the enterprise AI space. And with our experience on how to navigate within the enterprise landscape, we are quite well positioned to help with that."

People, Delivery Model & Visa Dynamics

Sanghrajka: "Difficult to say at this point in time. But I mean, mathematically, if you do more nearshoring and more offshoring, it should mean more margin, but it depends on to what extent you are able to do offshoring, nearshoring and to what extent we will end up doing more local hiring. So, I think it is going to be a balanced act there."

Capital Return & Inorganic Moves


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth2%–3% constant currencyFY26 full year
Operating margin20%–22%FY26 full year
Fresher hiringClose to 20,000FY26 full year
Buyback completionRs. 18,000 crores at Rs. 1,800/shareQ3 FY26, subject to shareholder approval
Versent JV closurePending regulatory approvalsExpected this year, exact timelines unknown
\$1.6 bn NHS mega deal ramp100% net new, start rampingThis fiscal year
Capital return policy85% of free cash flowOver 5-year period (in second year currently)

Key Metrics

MetricQ2 FY26
Revenue$5 bn+ quarterly, +2.2% QoQ and +2.9% YoY in constant currency
Operating margin21.0%, +20 bps QoQ; H1 margins 20.9% vs 21.1% in H1 FY25
Q2 EPS (₹)₹17.6, +13% YoY
Free cash flow$1.1 bn, 131% of net profit; H1 FCF conversion at 120%
Revenue growth guidance (FY26)2%–3% in constant currency, raised from 1%–3%
Operating margin guidance (FY26)20%–22%, unchanged
Large-deal TCV$3.1 bn, 67% net new; H1 deal wins $6.9 bn with 60%+ net new
Mega deal announced post-quarter$1.6 bn with UK NHS, 100% net new, not in Q2 TCV
Headcount332,000, net addition of 8,000 in Q2
Freshers hired (H1 FY26)12,000+, on track toward ~20,000 for full year
Voluntary attrition14.3%
Utilization (excl. trainees)85%, stable and within comfort range
Onsite mixReduced 40 bps QoQ and 60 bps in H1
DSO71 days, down 2 days YoY; including net unbilled down 5 days to 87 days
ROE29.1%